A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will highlight the potential artificial intelligence (AI) has to improve ...
Feb 27, 2024
0
1
A new research review to be given at a pre-congress day for this year's European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) will look at the many ways artificial intelligence can help prevent ...
Feb 27, 2024
4
1
The degree of severity to which someone experiences COVID-19 has a lot to do with the body's immune response to the SARS-CoV-2 virus and the infection it causes. Our immune system tailors antibodies to fight infections, so ...
Feb 21, 2024
0
62
LUMC research has shown that women who previously had a miscarriage due to COVID-19 are not at increased risk of having another miscarriage or a stillbirth. Nor are preventive drugs needed during the pregnancy.
Feb 19, 2024
0
9
A female white-eared opossum (Didelphis albiventris) found dead in 2021 in Bosque dos Jequitibás Park in the center of Campinas, one of the largest cities in São Paulo state, Brazil, died from rabies meningoencephalitis, ...
Feb 19, 2024
0
0
The U.S. Centers for Disease Control and Prevention is weighing whether to recommend another COVID booster shot this spring, most likely for those who are vulnerable to severe illness.
Feb 19, 2024
0
1
Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins ...
Feb 16, 2024
0
0
A review paper, published in the New England Journal of Medicine, focuses on how fungal diseases present in people with healthy immune systems and examines current diagnostics and treatments.
Feb 16, 2024
0
23
A common human gene mutation combination—found in about 5% of the U.K.'s Black population as well as millions of people worldwide with recent African ancestry—has been linked to a number of health conditions and poor ...
Feb 15, 2024
0
15
Women who receive an mRNA-based COVID-19 vaccination or booster during pregnancy can provide their infants with solid protection against symptomatic COVID-19 infection for at least six months after birth, according to a study ...
Feb 14, 2024
0
2
